We strive to innovate treatments and return individuals to daily activities. Through the use of passive sensing of biosignals we are working to improve our understanding of pain and support each individual’s return to wellness.
For over a decade our engineers have been optimizing our patented diagnostic tools.
We offer a tool for the quantitative measure of pain.
THERE IS AN URGENT NEED.
CHRONIC PAIN AFFECTS 100 MILLION INDIVIDUALS IN THE US ALONE. ONE THIRD OF THE US POPULATION ~ Institute of Medicine 2011 Report, Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research
SOME 1.5 BILLION OF THE WORLD’S 7 BILLION PEOPLE – 21% – CURRENTLY SUFFER FROM PAIN. – Wall Street BioBeat, Genetic Engineering and Biotechnology News, Jun 1, 2012 (Vol. 32, No. 11) Pain Management Market Ripe with Immediate Opportunities.